Table 2.
Eastern Cooperative Oncology Group Performance Status and laboratory data at diagnosis, during treatment, two month after treatment and last follow up at 69 month
| Diagnosis in 2012 | Month 1–2 | after 2 month | Month 3–6 | after 6 month | Month 6–9 | after 9 month | Month 11 + 12 | Month 13–21 | Month 23 | Month 69 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ECOG Performance Status | |||||||||||
| 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | |
| Laboratory Data at the start of treatment, during the treatment as maximum toxicity, restaging and last follow | |||||||||||
| White blood cell (×103 /μl) | 7.5 | 0.6 | 3.8 | 1.4 | 2.2 | 3.6 | 4.6 | 6.6 | 1.5 | 6.6 | 8.7 |
| Hemoglobin (g/dl) | 8.8 | 7.2 | 10.0 | 8.4 | 8.2 | 10.9 | 13.3 | 10.0 | 8.8 | 11.9 | 10.6 |
| Red blood cell (× 106 /μl) | 4.3 | 2.6 | 3.4 | 2.7 | 2.6 | 3.1 | 4.1 | 3.0 | 2.5 | 3.6 | 4.1 |
| Platelet (×103 /μl) | 431 | 74 | 144 | 178 | 240 | 225 | 289 | 209 | 113 | 245 | 491 |
| Creatinine (mg/dl) | 0.83 | 1.42 | 1.48 | 1.33 | 0.85 | 1.00 | 0.77 | 1.09 | 1.03 | 1.08 | 0.98 |
| AST (U/l) | 214 | 52 | 21 | 79 | 32 | 43 | 26 | 36 | 37 | 25 | 16 |
| ALT (U/l) | 129 | 117 | 16 | 118 | 30 | 50 | 22 | 41 | 53 | 18 | 17 |
| Total Bili (mg/dl) | 0.8 | 0.7 | 0.3 | 0.9 | 0.4 | 0.5 | 0.4 | 0.7 | 0.5 | 0.3 | 0.4 |
| GGT (U/l) | 50 | 176 | 62 | 70 | 31 | 37 | 24 | 91 | 123 | 36 | 16 |
| Albumin (g/l) | 34.4 | 22.7 | 30.9 | 30.9 | 40.7 | 34.9 | 45.9 | 33.9 | 29.3 | 42.1 | 38.5 |
| INR | 1.0 | 0.99 | 1.01 | 1.01 | 1.03 | 1.03 | – | 0.98 | 0.99 | – | 0.95 |